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ABSTRACT
Many Regulators of G protein Signaling (RGS) proteins accel-
erate the intrinsic GTPase activity of Gia and Gqa-subunits [i.e.,
behave as GTPase-activating proteins (GAPs)] and several act
as Gqa-effector antagonists. RGS3, a structurally distinct RGS
member with a unique N-terminal domain and a C-terminal
RGS domain, and an N-terminally truncated version of RGS3
(RGS3CT) both stimulated the GTPase activity of Gia (except
Gza) and Gqa but not that of Gsa or G12a. RGS3 and RGS3CT
had Gqa GAP activity similar to that of RGS4. RGS3 impaired
signaling through Gq-linked receptors, although RGS3CT in-
variably inhibited better than did full-length RGS3. RGS3 po-
tently inhibited GqaQ209L- and G11aQ209L-mediated activation
of a cAMP-response element-binding protein reporter gene and
GqaQ209L induced inositol phosphate production, suggesting
that RGS3 efficiently blocks Gqa from activating its downstream
effector phospholipase C-b. Whereas RGS2 and to a lesser
extent RGS10 also inhibited signaling by these GTPase-defi-
cient G proteins, other RGS proteins including RGS4 did not.
Mutation of residues in RGS3 similar to those required for
RGS4 Gia GAP activity, as well as several residues N terminal to
its RGS domain impaired RGS3 function. A greater percentage
of RGS3CT localized at the cell membrane than the full-length
version, potentially explaining why RGS3CT blocked signaling
better than did full-length RGS3. Thus, RGS3 can impair Gi-
(but not Gz-) and Gq-mediated signaling in hematopoietic and
other cell types by acting as a GAP for Gia and Gqa subfamily
members and as a potent Gqa subfamily effector antagonist.
A variety of hormones, neurotransmitters, and physical
stimuli trigger intracellular responses by binding to seven
transmembrane receptors. These receptors link to down-
stream signaling pathways by activating heterotrimeric G
proteins and, as such, are designated G protein-coupled re-
ceptors (GPCRs). In their inactive state heterotrimeric G
proteins are composed of three subunits: a, b, and g (see
reviews by Bourne et al., 1991; Hepler and Gilman, 1992;
Gudermann et al., 1995; Neer, 1995). There are 23 a-sub-
units divided into four major subfamilies based on primary
sequence homology and common downstream effectors
termed Gsa, Gia, Gqa, and G12/13a. There are five different
b-subunits and 10 different g-subunits. Upon ligand binding
a GPCR stimulates the a-subunit of a heterotrimeric G pro-
tein to exchange GDP for GTP. In the GTP-bound form, Ga
dissociates from Gbg, each of which can activate downstream
effectors. Signaling is halted when the GTP-bound Ga-sub-
units hydrolyze GTP to GDP, which results in reassembly
with Gbg-subunits to form inactive heterotrimers.
Recent genetic and biochemical experiments have revealed
the existence of a novel family of proteins termed Regulators
of G protein Signaling (RGS) that act as GTPase-activating
proteins (GAPs) for the Gia and Gqa subfamilies (De Vries et
al., 1995; Berman et al., 1996b; Dohlman et al., 1996; Druey
et al., 1996; Hunt et al., 1996; Koelle and Horvitz, 1996;
Watson et al., 1996). Recently, p115 RhoGEF, which contains
a highly diverged RGS domain, was shown to be a G12a GAP
(Kozasa et al., 1998); however, no Gsa GAP has been shown to
exist. Many RGS proteins bind tightly to the GDP-AlF4
2-
activated forms of Gia and Gqa, a conformation that mimics
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the transition state in the GTPase reaction, and thereby
accelerate the intrinsic rate at which the Ga-subunits hydro-
lyze GTP (Berman et al., 1996a, b; Hunt et al., 1996; Watson
et al., 1996; Hepler et al., 1997; Popov et al., 1997). Analysis
of crystals of RGS4 complexed with Gia1-GDP-AlF4
2 revealed
that the 120-amino acid RGS domain (also referred to as the
RGS box) forms a four-helix bundle that directly contacts the
three “switch regions” in Gia1 (Tesmer et al., 1997). These
regions undergo the greatest conformational change during
GTP hydrolysis, and specific amino acids in RGS4 appear to
stabilize them in a transition state facilitating the hydrolysis
reaction. The specificity of RGS4 protein for the Gia and Gqa
subfamilies likely relies on the structure of the switch re-
gions. Based on the RGS4-Gia1 and Gsa crystal structures,
the failure of RGS4 to bind Gsa is secondary to specific amino
acids in Gsa and RGS4 that disrupt the interaction by steric
overlap, charge repulsion, and creations of small cavities at
the interface (Sunahara et al., 1997; Tesmer et al., 1997). The
failure of RGS4 to act as a GAP for G12a is more easily
explained because amino acid differences in the G12a switch
regions would disrupt the surface and charge complementa-
rity of the interface observed between RGS4 and Gia1 (Tes-
mer et al., 1997).
Several studies have indicated that the RGS protein RGS3
impairs Gi- and Gq-mediated signaling. RGS3 inhibited in-
terleukin-8 induced mitogen-activated protein kinase activa-
tion (Druey et al., 1996) and inositol triphosphate (IP3) pro-
duction in response to signaling through the gonadotropin-
releasing hormone (GnRH) receptor (Neill et al., 1997), Gi-
and Gq-linked signaling pathways, respectively. A truncated
form of RGS3 (RGS3CT) impaired Gq- and Gi-mediated sig-
naling as well as Gs-triggered signaling, whereas a full-
length version inhibited only Gi-mediated signaling (Chat-
terjee et al., 1997a). In contrast, expression of a full-length
RGS3 in a human mesangial cell line partially blocked an
endothelin-1-induced calcium flux, a Gq-mediated response
(Dulin et al., 1999). The present study explored the relative
effectiveness of RGS3, RGS3CT, and RGS4 in modulating
Gq-mediated signaling. We provide information concerning
the relative GAP activity of RGS3, RGS3CT, and RGS4 for
Gqa, as well as Gia, Gza, Gsa, and G12a. RGS3 emerges as a
potent inhibitor of Gq-mediated signaling by acting not only
as a Gq GAP but also as an antagonist of GTP-bound Gq
signaling.
Experimental Procedures
Plasmids. To make His6-RGS3 and His6-RGS3CT (amino acids
314–520) polymerase chain reaction (PCR) fragments generated
from RcCMV-RGS3 were inserted into the NdeI/XhoI sites of the
bacterial expression vector pET15b (Novagen, Madison, WI) in frame
with the hexahistidine tag. To make glutathione S-transferase
(GST)-RGS3, a PCR product generated from RcCMV-RGS3 was di-
rectionally cloned in the BamHI and EcoRI sites of the bacterial
expression vector pGEX2T. To make FLAG-RGS3NT (RGS3 1–313),
FLAG-RGS3CT (314–520), and FLAG-RGS3, the appropriate PCR
products were subcloned into pFLAGCMV-2. FLAG-RGS3 E419A/
N420A (EN mutant), FLAG-RGS3 R499A/F500A (RF mutant),
FLAG-RGS3 K350A/K353A/liter356A (KKL mutant), and FLAG-
RGS3 E386A/E387A (EE mutant) were created by site-directed mu-
tagenesis of pFLAGCMV-2 RGS3 (Stratagene, La Jolla, CA). Expres-
sion vectors for the beta-adrenergic receptor, GqaQ209L and
G11aQ209L, were kindly provided by Dr. S. Gutkind (National Insti-
tutes of Health, Bethesda, MD). The expression vectors for RGS1,
RGS2, RGS3, and RGS4 have been previously described (Druey et
al., 1996). Dr. P. Casey (Duke University, Durham, NC) and Dr. J.
Gunzburg (Institut Curie, Paris, France) kindly provided the RGS10
and RGS14 expression vectors, respectively. The RGS5 expression
vector was created by PCR with known sequence information and
subcloned in-frame with a hemagglutinin (HA)-tag into pCRIII. The
cAMP-response element binding (CREB)-b-galactosidase reporter
plasmid was kindly provided by Dr. R. Cone (Vollum Institute, OR).
The pFA2-Elk1, pFR-luc, and pSRE-luciferase plasmids were pur-
chased (Stratagene).
Purification of Recombinant Proteins. The His-tagged recom-
binant RGS protein expressions were performed in Escherichia coli
BL21(DE3) by induction with 0.5 mM isopropylthio-b-galactoside at
30°C for 2 h. The recombinant proteins were batch purified under
nondenaturing conditions with NiNTA beads (Qiagen, Santa Clara,
CA) and eluted with an imidazole gradient. The purified protein
fractions were dialyzed against the wash buffer and stored at 270°C.
To make the GST fusion proteins, the appropriate constructs were
transformed into E. coli BL21(DE3) pLysS, and induced with 0.5 mM
isopropylthio-b-galactoside for 2 h at 30°C. Recombinant protein
purification was carried out in ice-cold phosphate-buffered saline
(PBS)/1% Triton X-100 with glutathione-Sepharose beads (Pharma-
cia, Piscataway, NJ). After purification the GST-fusion protein was
stored on the beads at 4°C or eluted and kept at 270°C.
Immunocytochemistry. HEK 293T cells were grown on a cover
slip in a 10-cm plate [Dulbecco’s modified Eagle’s medium (DMEM),
10% fetal calf serum (FCS)] until they were 50% confluent. Trans-
fection with pFLAGCMV-2 RGS3, pFLAGCMV-2 RGS3CT, or empty
vector was performed with calcium phosphate. The medium was
changed 8 h after transfection, and cells were harvested 2 days later.
The cover slips were washed with PBS, covered with 50% acetone/
50% methanol, and kept at 4°C. After 1 h the liquid was removed,
and the cover slips were air dried. Blocking of nonspecific binding
sites was performed for 2 h at room temperature with PBS contain-
ing 10% FCS and 2% bovine serum albumin (BSA). Then the slides
were incubated with mouse anti-FLAG monoclonal antibody (1:1000)
in 2% BSA in PBS for 2 h at room temperature. After the sample was
washed with PBS for 10 min, the slides were incubated for 2 h with
fluorescein isothiocyanate-conjugated affinity-purified goat anti-
mouse Ig 1:1000 in PBS containing 2% BSA. Then, cover slips were
washed four times with PBS, air dried, and mounted on slides.
Measurement of GAP Activity. Measurements of kcat for hydro-
lysis of GTP for Gza and G12a were determined as described (Berman
et al., 1996b). Direct measurement of the kcat for GTP hydrolysis by
Gqa required the use of the mutant GqaR183C, which is based on the
analogous mutation in Gsa, R174A (Freissmuth and Gilman, 1989),
and Gia, R178C (Kleuss et al., 1994). Although this mutation in Gia
markedly reduces its kcat for GTP hydrolysis, the mutant protein
retains its responsiveness to RGS proteins (Chediac and Ross, 1999).
The method used for Gza hydrolysis of GTP is a modification of that
previously described (Berman et al., 1996b). In this study similar
methods were used for Gia to approximate as closely as possible the
conditions for Gqa, Gza, and G12a. Briefly, G protein a-subunits were
loaded with [g32P]GTP (5–10 mM, Amersham, Cleveland, OH) in the
presence of 50 mM HEPES (pH 7.4), 0.1 mg/ml BSA, 1 mM dithio-
threitol, and either 5 mM EDTA and 0.05% C12E10 (for Gia) or 10 mM
free Mg21, 30 mM (NH4)2SO4, 4% glycerol, and 5.5 mM 3-[(cholami-
dopropyl)dimethylammonio]-1-propanesulfonic acid (CHAPS; for
Gqa). The loading reactions were performed for 20 min at 30°C for Gia
or 2 h at 20°C for Gqa. After incubation, free [g
32P]GTP and
[32P]orthophosphate were removed by chromatography on Sephadex
25 containing 50 mM HEPES (pH 7.4), 1 mM CHAPS, 1 mM dithio-
threitol, 18 mg/ml BSA, and either 0.1% octylglucoside plus 5 mM
EDTA (Gia) or 10 mM free Mg
21 (Gqa). Hydrolysis of bound [g
32P]GTP
was initiated by addition of 1 mM nonradioactive GTP, 10 mM MgCl2
(for Gia), and RGS protein or buffer. Reaction temperatures for Gia
and Gqa were 4 and 20°C, respectively. Aliquots were removed at the
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indicated times and added to 5% (w/v) Norit (Norit Americas Inc.,
Atlanta, GA) in 50 mM NaH2P04. After the sample was centrifuged
at 1500 rpm for 10 min, aliquots of supernatant containing 32Pi were
counted by liquid scintillation spectrometry.
Assessment of Reporter Gene Activity. HEK 293T cells were
plated in 10-cm dishes and transfected using calcium phosphate
when the cells were 50% confluent. For Gq-mediated signaling, HEK
293T were transfected with constructs that direct the expression of
the muscarinic type 1 (M1) receptor (2 mg/plate), FLAG-RGS3 or
HA-RGS4, and CREB b-galactosidase reporter plasmid (2 mg/plate)
receptor. In some experiments 0.5 mg of a cytomegalovirus-luciferase
plasmid (Promega) was used to monitor the transfection efficiency.
pcDNA was used to normalize the total amount of DNA used per
plate. The medium was replaced 8 h later, and 48 h after transfection
the cells were stimulated for 6 h with 1 mM carbachol (Sigma, St.
Louis, MO) and then harvested. For Gs-mediated signaling,
HEK293T cells were transfected with constructs that direct the
expression of the beta-adrenergic receptor (2 mg/plate), CREB-b-
galactosidase (1 mg/plate), and FLAG-RGS3 or HA-RGS4. Forty-
eight hours after transfection, the cells were stimulated for 6 h with
10 mM isoproterenol (Sigma) and harvested. For GqaQ209L- and
G11aQ209L-mediated signaling, HEK 293T cells were transfected
with constructs that direct the expression of CREB-b-galactosidase
(1 mg/plate), GqaQ209L or G11aQ209L (0.5 mg/plate), and different
RGS protein expression vectors. The cells were harvested 24 h after
transfection. The pelleted cells from the various signaling assays
were lysed in 100 ml of reporter lysis buffer (Promega) for 20 min on
ice. After the sample was centrifuged, 10 ml of the supernatant were
tested for b-galactosidase activity with galactan chemiluminescent
substrate (Tropix, Bedford, MA) or luciferase activity with a lucif-
erase substrate (Promega). Data were normalized by protein concen-
tration (Bradford assay, Bio-Rad, Hercules, CA) or by the activity
levels of a control reporter gene. The expression levels of various
RGS proteins were confirmed by immunoblotting for the appropriate
epitope, HA or FLAG.
Western Blotting. The HS-Sultan, Molt-4, Jurkat, COS-7, PC-
12, RAMOS, HeLa, and K562 cell lines were obtained from the
American Tissue Culture Collection (Rockville, MD). All the lym-
phoid cell lines were maintained in RPMI 1640 supplemented with 5
to 10% FCS, and the nonlymphoid cells were maintained in DMEM
plus 10% FCS. Cell lysates of various cell lines were obtained by
adding 1 3 107 cells to a solution containing 150 mM NaCl, 50 mM
Tris (pH 7.5), 5 mM EDTA, and 1% Nonidet P-40, along with a
cocktail of protease inhibitors for 20 min on ice. The detergent-
insoluble material was removed by microcentrifugation for 10 min at
4°C. In some experiments, cells were lysed in hypotonic buffer (20
mM Tris-HCl, pH 7.5, with protease inhibitors), sonicated, subjected
to a low-speed spin to remove the nuclei, and fractionated into a
membrane-enriched and -depleted fraction by centrifugation at
52,000 rpm for 30 min. A total of 50 to 100 mg of protein (Bio-Rad
assay) from each sample were fractionated by SDS-polyacrylamide
gel electrophoresis and transferred to pure nitrocellulose. Mem-
branes were blocked with 3% BSA in TTBS (Tris-HCl, NaCl, Tween
20) for 1 h and then incubated with an appropriate dilution of the
primary antibody in 1.5% BSA and 0.05% sodium azide in TTBS
overnight. The blots were washed twice with TTBS before the addi-
tion of a biotinylated goat-anti rabbit Ig (DAKO, Carpinteria, CA)
diluted 1:5000 in TTBS containing 10% FCS. After a 1-h incubation,
the blot was washed twice with TTBS and then incubated with
streptavidin conjugated to horseradish peroxidase (DAKO). The sig-
nal was detected by enhanced chemiluminescence following the rec-
ommendations of the manufacturer (Amersham). The antisera
against RGS3 were used at a 1:400, and the mouse monoclonal
antibodies were reactive with FLAG or HA (Covance, Richmond, CA)
at a 1:1000 dilution. The RGS3 antiserum used in this study was
prepared against recombinant RGS3 in rabbits and recognized re-
combinant RGS3, transfected RGS3, and a band of similar mobility
in cellular lysates. Another rabbit antiserum raised against a con-
served peptide in RGS2 and RGS3 also recognized recombinant
RGS3, transfected RGS3, and the same bands as did the first anti-
serum (data not shown).
Inositol Phosphate Production. COS-7 cells were transfected
with LipofectAMINE (1:8) after serum starvation for 24 h. Twenty-
four hours after transfection, the culture medium was replaced with
inositol-free DMEM containing 5% FCS and 1 mM sodium pyruvate
for 2 h. Next, 2 mCi/ml of myo-[2-3H]inositol (Amersham) were added,
and 15 min later, 10 mM LiCl was added. The cells were incubated
for an additional 14 h and washed with phosphate-buffered saline,
Fig. 1. Expression and intracellular
localization of RGS3. A, Different cell
lysates were analyzed by immunoblot-
ting with an anti-RGS3 antiserum
(lanes 1–16). Hs-Sultan cells were
stimulated with LPA (1027 M) for the
indicated times. Molecular mass
markers and the origin of the cell ly-
sates are indicated. B, Localization of
RGS3 and RGS3CT. Cos-7 cells were
transfected with constructs directing
expression of FLAG-RGS3 or FLAG-
RGS3CT, or with a control plasmid.
Immunofluorescent staining with a
FLAG antibody is shown.
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and then 0.5 ml of 20 mM formic acid was added to each well. After
an incubation period of 30 min, the supernatant was collected and a
second extraction was performed. Each 1-ml extract was neutralized
to pH 7.5 with 7.5 mM HEPES and 150 mM KOH. The supernatants
were centrifuged for 2 min at 15,000g and collected, and each was
loaded onto to a 0.5-ml Dowex AG-X8 column (Bio-Rad), which had
been previously washed with 2 ml of 1 M NaOH and 2 ml 1 M formic
acid and five washes of 5 ml of water. After the sample was loaded,
the column was washed with 5 ml of water, 5 ml of 5 mM borax, and
60 mM sodium formate. The columns were eluted with 3 ml of 0.9 M
ammonium formate and 0.1 M formic acid. To 10 ml of CytoScint, 0.2
ml of each elution was added and the sample was analyzed via
scintillation counting.
Results
Expression and Localization of RGS3. We generated
an RGS3-specific antiserum to delineate the expression of
RGS3 in various cell types. To do so we immunized rabbits
with recombinant RGS3. The RGS3 was produced as a GST-
fusion protein in E. coli and purified on glutathione-agarose
before cleaving it from GST with factor Xa. The antiserum,
but not the preimmune sera, recognized recombinant and in
vitro translated RGS3, and its detection of RGS3 could be
blocked by the immunizing peptide (data not shown). The
analysis of cellular lysates prepared from a variety of cell
lines revealed an approximately 75-kDa protein (Fig. 1A)
that comigrates with recombinant RGS3 or epitope-tagged
RGS3 expressed in HEK 293T cells (data not shown). The
migration of RGS3 did not coincide with its predicted molec-
ular mass (54 kDa), suggesting a post-translational modifi-
cation or simply aberrant migration. A similar migration of
RGS3 has been found with a different antiserum (Dulin et
al., 1999). A third antiserum raised against a shared epitope
in RGS2 and RGS3 also recognized recombinant RGS3 and
detected bands in cellular lysates similar to the other two
antisera (S. Sinnarajah, unpublished observation). Three cell
lines (K562, COS-7, and PC-12) expressed RGS3 at relatively
high levels, whereas Hs-Sultan, RAMOS, HEK 293T, and
NG108-15 had moderate levels, and HeLa, Nalm-6, Jurkat,
K562, and Molt-4 had either low or undetectable amounts.
Some cell lines had a doublet at approximately 75 kDa
(Nalm-6, Jurkat, K562, and PC-12). We also examined
whether lysophosphatidic acid (LPA) raised the levels of
RGS3 expression in HS-Sultan cells, a human B lymphocyte
cell line in which RGS1 can be induced by treatment with
platelet-activating factor (Druey et al., 1996). Treatment
with LPA resulted in a rapid enhancement of RGS3 expres-
sion with an increase noted by 1 h after stimulation (Fig. 1A).
Immunofluorescent staining with an epitope-specific anti-
body localized RGS3 and RGS3CT largely in the cytosol of
transfected COS cells (Fig. 1B), although this approach pro-
vided little information concerning the amounts of RGS3 and
RGS3CT associated with the cell membrane (see below).
RGS3 and RGS3CT Enhanced the GTPase Activity of
Gia and Gqa but Not That of Gsa, G12a, or Gz. The previ-
ously cited differences of RGS3 and RGS3CT on signaling
pathways prompted us to compare the GAP activity of RGS3
Fig. 2. RGS3 and RGS3CT enhance
the GTPase activity of Gia1 and Gqa.
Different concentrations of H6-RGS3
(left panels) and H6-RGS3CT (right
panels) were tested for their ability to
accelerate the GTPase activity of
MyrGia1 (top panels) and Gqa R183C
(bottom panels). The following concen-
trations of RGS3 or RGS3CT were
added to the MyrGia1 GTPase hydro-
lysis reactions: none (l), 20 nM (Œ),
100 nM (f), or 500 nM (F). The follow-
ing concentrations of RGS3 or
RGS3CT were added to the GqaR183C
GTPase hydrolysis reactions: none
(l), 4 nM (), 20 nM (Œ), 100 nM (f),
or 500 nM (F).
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and RGS3CT for different Ga-subunits. We analyzed the
effects of RGS3 and RGS3CT on the GTPase activity of Gia1
and Gqa during a single catalytic turnover (Fig. 2). The Gqa
GTPase assays required the use of the mutant GqaR183C
(Chediac and Ross, 1999), which is based on analogous mu-
tations in Gsa, R174A (Freissmuth and Gilman, 1989), and
Gia, R178C (Kleuss et al., 1994). This Gia mutant has a
significantly reduced kcat of GTP hydrolysis but retains sen-
sitivity to RGS proteins (Kleuss et al., 1994; Berman et al.,
1996a). The recombinant G proteins were loaded with
[32P]GTP, and GTP hydrolysis was initiated in the absence or
presence of increasing concentrations of RGS proteins. Both
RGS3 and RGS3CT stimulated GTP hydrolysis by Gia1 and
Gqa, indicating that the N-terminal domain of RGS3 does not
alter the ability of RGS3 to act as a GAP.
Next, we compared the effects of RGS3 and RGS3CT with
those of RGS4 on the GTPase activity of different Ga-sub-
units (Fig. 3). We found that RGS3 and RGS3CT enhanced
the Gqa GTPase activity to a degree similar to that of RGS4,
whereas RGS4 was a superior GAP for Gia1. Strikingly, in the
Gza GAP assay, RGS4 had significant activity, whereas
RGS3 had none. Despite the ability of RGS3CT to inhibit
Gs-mediated signaling (Chatterjee et al., 1997a), both RGS3
and RGS3CT failed to act as a GAP for Gsa (Fig. 5). Finally,
RGS3 and RGS3CT did not alter the GTPase activity of G12a
(data not shown).
RGS3 Impairs Signal Transduction through the
Muscarinic M1 Receptor and Beta-Adrenergic Recep-
tor More Effectively Than Does RGS4. RGS3 inhibited
IP3 production in response to signaling through the GnRH
receptor (Neill et al., 1997), whereas RGS4 did not despite its
ability to inhibit Gq-mediated signaling in other experiments
(Hepler et al., 1997; Huang et al., 1997). RGS3CT inhibited
platelet-activating factor-induced IP3 production, but RGS3
did not (Chatterjee et al., 1997a). To explore the relative
effectiveness of RGS3 and RGS4 in inhibiting signal trans-
duction through another Gq-coupled GPCR, we transiently
transfected HEK293T cells with a construct that directs the
expression of the M1 receptor in the presence or absence of
increasing amounts of expression vectors for RGS3 or RGS4.
Signaling through the M1 receptor was monitored with a
CREB-driven b-galactosidase reporter plasmid. Activated
Gqa is known to stimulate phospholipase C-b to convert phos-
phatidylinositol bisphosphate into IP3 and diacylglycerol. IP3
stimulates Ca12 release from intracellular stores activating
CaM kinase IV, which in-turn phosphorylates the transcrip-
tion factor CREB. This results in CREB activation and tran-
scription of the pCREB/b-galactosidase reporter gene (Chen
Fig. 3. Comparison of RGS3, RGS3CT, and RGS4 on the GTPase activity of Gia1, Gqa, Gsa, or Gza. H6-RGS3, H6-RGS3CT, and H6-RGS4 were tested
for their enhancement of the GTPase activity of Gia1 [top left: 100 nM RGS4 (F), 100 nM RGS3 (f), 100 nM RGS3CT (Œ), buffer ()], GqaR183C [top
right: 150 nM RGS4 (F), 150 nM RGS3 (f), 150 nM RGS3CT (Œ), buffer ()], Gsa [bottom left: 1 mM RGS3 (F),1 mM RGS3CT (f), buffer (Œ)], or Gza
[bottom right: 150 nM RGS4 (F), 150 nM RGS3 (f), 150 nM RGS3CT (Œ), buffer ()].
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et al., 1995). Carbachol stimulation of the M1-transfected
cells resulted in a 10- to 20-fold increase in reporter gene
activity. We observed a dose-dependent inhibition of reporter
gene activity by RGS3 (Fig. 4). RGS4 also inhibited signaling
through the M1 receptor; however, the maximal level of in-
hibition was significantly less than that observed with RGS3.
Immunoblotting cell lysates for RGS3 and RGS4 revealed the
expected increase in RGS3 and RGS4 expression in the trans-
fected cells (Fig. 4). Similar experiments were performed
with RGS3CT, and it inhibited reporter gene activity to an
even greater extent than did full-length RGS3 (data not
shown). Thus, RGS3 inhibits Gq-mediated signaling through
the M1 receptor in HEK293T cells much better than does
RGS4.
In addition to its inhibition of Gq-mediated signaling,
RGS3T reduced the calcitonin gene-related peptide stimu-
lated increase of cAMP levels in BHK cells, a response me-
diated by Gsa (Chatterjee et al., 1997a). To evaluate whether
RGS3 or RGS4 inhibited Gs-mediated signaling in HEK 293T
cells, we transfected constructs that direct the expression of
the beta-adrenergic receptor and either RGS3 or RGS4. Sig-
naling via the beta-adrenergic receptor was monitored with
the same reporter plasmid that was used for Gq-mediated
signaling. Gsa-GTP activates adenylyl cyclase, which in-
creases cAMP levels and results in protein kinase A activa-
tion. Activated protein kinase A phosphorylates CREB, re-
sulting in CREB activation and enhanced transcription of the
pCREB/b-galactosidase reporter gene (Chen et al., 1995).
Isoproterenol induced an approximately 10-fold increase in
reporter gene activity. To observe a consistent inhibition in
reporter gene activation, we needed to transfect 5 mg/plate of
RGS3 expression vector, whereas a similar level of RGS4 had
only a modest inhibitory effect (Fig. 4). Thus, in HEK 293T
cells, high expression levels of RGS3 can inhibit Gs-mediated
signaling.
RGS3 Inhibits GqaQ209L and G11aQ209L Signaling.
Although RGS3, RGS3CT, and RGS4 had equivalent GAP
activity for Gqa, RGS3 better inhibited signaling through the
Gq-linked GnRH (Neill et al., 1997) and M1 receptors than
did RGS4. Although selective RGS protein-receptor interac-
tions were reported recently (Xu et al., 1999), we suspected
that other mechanisms might also be important. RGS2 po-
tently inhibited Gq-signaling irrespective of the receptor
used, in a manner superior to that of RGS1, RGS4, and
RGS16 (Xu et al., 1999). Perhaps RGS2 and RGS3 inhibit the
interaction of GTP-Gqa with its effectors better than do other
RGS proteins. To establish an in vivo system to test the
effectiveness of RGS proteins to act as effector antagonists
for Gq subfamily members, we expressed constitutively ac-
tive mutants of Gqa and G11a and evaluated their ability to
activate three different reporter genes. Varying concentra-
tions of G11aQ209L or GqaQ209L were transfected into HEK
293T cells along with a CREB, a serum response element, or
an Elk-1 reporter gene (Table 1). Both G11aQ209L and
GqaQ209L potently activated the CREB reporter gene, but
not the serum response element and Elk-1 reporter genes.
G11aQ209L and GqaQ209L had biphasic dose-response
curves for CREB reporter gene activation with an optimal
concentration of transfected DNA between 0.1 and 0.5 mg per
transfection. When optimized, G11aQ209L activated the
CREB reporter 2-fold better than did GqaQ209L.
Next, we screened a panel of RGS proteins for their effect
on GqaQ209L-mediated activation of the CREB reporter
gene. Expression constructs designed to express RGS1,
RGS2, RGS3, RGS4, RGS5, RGS10, or RGS14 were trans-
fected into HEK 293T in the presence or absence of
GqaQ209L along with the CREB reporter gene (Fig. 5A).
Transfection efficiency was monitored with a control plas-
mid, which expressed luciferase from a cytomegalovirus pro-
moter. All the RGS proteins were epitope tagged and well
expressed as assessed by immunoblotting (data not shown).
We found that RGS3 inhibited GqaQ209L-induced activation
of the CREB reporter gene, whereas RGS4 had only a modest
effect. Of the RGS proteins we tested, RGS2 was slightly
superior to RGS3, and RGS10 had a modest effect. In con-
trast, RGS1 and RGS5 had minimal effects, and RGS14
consistently enhanced GqaQ209L-mediated activation of
CREB activity. The same panel of RGS proteins was exam-
ined with G11aQ209L to activate the CREB reporter gene.
Again RGS2 and RGS3 inhibited; however, RGS5 and RGS4
had no effect at the concentration tested. Similar to the
analysis of GqaQ209L signaling, RGS10 had a modest inhib-
TABLE 1
Fold activation of different reporter genes by G11aQ209L and
GqaQ209L
HEK 293T cells were transfected with constructs directing the expression of
G11aQ209L (0.5 mg/plate) or GqaQ209L (0.5 mg/plate) in the presence of CREB-b-
galactosidase (0.5 mg/plate), SRE-luciferase (0.5 mg/plate), or pFR-luciferase (0.1
mg/plate) plus pFA2-Elk-1 (0.5 mg/plate). Transfection efficiency was normalized
using a cytomegalovirus-b-galactosidase or cytomegalovirus-luciferase control vec-
tor. The amount of luciferase or b-galactosidase activity was measured 1 day later.
Data are reported as the fold activation 6 2 S.D. of three experiments performed in
duplicate compared to the activity of the reporter genes in the absence of activator.
CREB SRE Elk-1
GqaQ209L 4.8 6 0.7 1.9 6 0.6 1.1 6 0.6
G11aQ209L 9.1 6 1.0 3.5 6 0.2 0.9 6 0.2
Fig. 4. RGS3 impairs signal transduction through Gq- and Gs-linked
receptors. HEK 293T cells were transfected with constructs directing the
expression of the M1 receptor (2 mg) or the b-adrenergic receptor (2 mg)
and a CREB b-galactodase reporter construct (5 mg) in the presence of
varying concentrations of pcDNA-RGS3HA (open bars) or pcDNA-
RGS4HA (black bars) expression vector. The transfected cells were ex-
posed to carbachol or isoproterenol for 8 h before analysis of reporter gene
activity. Data are shown as percentages of activity obtained in the ab-
sence of RGS protein. In all experiments the agonists induced at least a
10-fold increase in reporter gene activity in the absence of RGS proteins.
Expression of the transfected RGS plasmid was verified by HA immuno-
blotting. Results are from 12 independent experiments. Error bars, S.D.
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itory effec,t and RGS14 augmented the response, although to
a lesser degree than previously. Next we directly compared
RGS3 and RGS4 (Fig. 5B). The lowest amount of RGS3
expression vector tested (0.2 mg) was superior to the highest
concentration of RGS4 tested (2 mg). Thus, despite their
similar GAP activity for Gqa, 10-fold less RGS3 inhibits sig-
naling by GqaQ209L and G11aQ209L better than did RGS4.
Analysis of the Effects of RGS3 Mutant Proteins on
G11aQ209L Signaling. Constructs that direct the expres-
sion of two RGS3 point mutants, EN mutant and RF mutant,
were created based on the residues in RGS4 known to be
important in its interaction with Gia and necessary for its
GAP activity for Gia (Druey and Kehrl, 1997; Tesmer et al.,
1997; Srinivasa et al., 1998). Expression vectors for two other
RGS3 mutant proteins, KKL mutant and EE mutant were
created based on residues noted to be conserved in the N-
terminal region of four RGS proteins that are Gqa GAPs
(RGS1, RGS2, RGS3, and RGS4). HEK 293T cells were trans-
fected with FLAG-RGS3 or one of the constructs that ex-
presses a FLAG-tagged mutant protein in the presence of
G11aQ209L and the CREB reporter gene. Similar levels of
expression of the wild-type RGS3 and the RGS3 mutant
proteins were observed by immunoblotting with a FLAG
monoclonal antibody. We found that the EN and RF mutant
proteins had significantly less activity than the wild-type
protein, although the mutations did not totally abolish their
activity (Fig. 6). In addition both the KKL mutant and the EE
RGS3 mutant proteins had less activity than the wild-type
protein. The KKL mutation was the more detrimental and
indicates that region N terminus to the RGS domain is nec-
essary for optimal inhibition of Gq/11-mediated signaling.
To verify these results in a different cell type and with a
different assay system of Gq signaling, we examined the
effects of RGS3 and RGS4 on inositol phosphate generation
after expression of GqaQ209L in COS-7 cells. The expression
of GqaQ209L in COS-7 cells resulted in a 12-fold increase in
the generation of inositol phosphates. RGS3 significantly
reduced GqaQ209L-induced inositol phosphate accumulation,
whereas RGS4 was ineffective (Fig. 7). The inhibitory effects
of RGS3 were not due its N-terminal 314 amino acids, be-
cause the C-terminal 206 amino acids were more effective
than the full-length protein, and the N terminus itself had no
effect. Again, the RGS3 EN and RF mutants were impaired
compared to wild-type RGS3 in their inhibition of GqaQ209L
induced inositol phosphate accumulation. Also, similar to the
previous results, the RGS3 KKL mutant was significantly
compromised, whereas the RGS3 EE mutant was closer to
that of wild type.
Finally, to address why RGS3CT outperforms full-length
RGS3 in the Gq-mediated-signaling experiments (Chatterjee
et al., 1997b; Fig. 8A) and yet had equivalent levels of GAP
activity for Gqa (Fig. 3), we analyzed whether RGS3 and
RGS3CT differed in the subcellular localization before or
after expression of GqaQ209L. We transfected Cos-7 cells
transfected with epitope-tagged versions of RGS3 or RGS3CT
in the presence or absence of GqaQ209L and prepared cell
lysates, the membrane-enriched and membrane-depleted
fractions of which we fractionated. Immunoblotting for
epitope-tagged RGS3 or RGS3CT revealed higher levels of
RGS3CT in both the absence of GqaQ209L and following the
expression of GqaQ209L (Fig. 8B). Before expression of
GqaQ209L, we found 3-fold more RGS3CT than RGS3 in the
membrane-enriched fraction, and after expression of the GT-
Pase-deficient G-protein, we detected approximately 75%
Fig. 5. Comparison of the effects of different RGS proteins on Gq signaling. A, GqaQ209L- and G11aQ209L-mediated CREB activation is inhibited by
RGS proteins. HEK 293T cells were transfected with constructs directing the expression of GqaQ209L (0.5 mg/plate) or G11aQ209L (0.5 mg/plate) in the
presence of CREB-b-galactosidase (0.5 mg/plate) and different RGS protein expression vectors (1 mg/plate). Transfection efficiency was monitored by
cotransfection with cytomegalovirus-luciferase (0.1 mg/plate). Luciferase and b-galactosidase activity were measured 24 h after transfection. Data are
reported as the percentages of control 6 2 S.D. of three experiments performed in duplicate. The control is cells transfected with the activated G
protein in the presence of an irrelevant plasmid. B, A direct comparison of the effects of RGS3 and RGS4 on G11aQ209L signaling. This experiment
is similar to that shown in A except increasing concentrations of constructs that direct the expression of FLAG-RGS3 or FLAG-RGS4 were transfected.
Data are from one experiment performed in duplicate and representative of two others performed. The data are expressed as percentages of activation
compared with control transfections without RGS protein. The immunoblot was performed with a FLAG, and the signal was detected by enhanced
chemiluminescence.
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more RGS3CT than RGS3 in the membrane-enriched frac-
tion. These results indicate that under steady-state condi-
tions the N terminus of RGS3 may negatively effect the
localization of the RGS3 to its likely site of action at the
plasma membrane, which is in part overcome after cellular
activation.
Discussion
The observations described above extend our knowledge of
RGS3 as a unique member of the RGS family. RGS3 is
expressed in multiple cell tissues including in hematopoietic
cells. It is a potent inhibitor of Ga-mediated signaling, and it
accelerates the GTPase activity of Gia1 and Gqa but not Gza,
G12a, or Gsa. GTPase-deficient forms of Gqa and G11a are
potent activators of a CREB reporter gene, and RGS3 inhib-
its their ability to activate the reporter gene. RGS3 amino
acid residues in the putative RGS3/Gqa contact site, as well
as N terminal to the RGS domain, are necessary for RGS3 to
inhibit the activation of downstream effectors by GTPase-
deficient forms of G11a and Gqa. The N terminus of RGS3 may
regulate its GAP activity by limiting access of full-length
RGS3 to Ga-subunits at the cell membrane.
Analysis of RGS3 mRNA expression has revealed multiple
RGS3 mRNA transcripts present at high levels in lung, kid-
ney, and muscle tissue (Druey et al., 1996). One major im-
munoreactive RGS3 band of 75 kDa was present in the cell
lysates (in some instances a doublet was noted). When
epitope-tagged versions of RGS3CT and RGS3NT are ex-
pressed in COS cells we have observed that RGS3NT is a
doublet and RGS3CT is a single band (S. Sinnarajah, unpub-
lished observation). This suggests that the N-terminal por-
tion of RGS3 may be modified to account for the doublet
noted by immunoblotting. The original RGS3 cDNA was iso-
lated from a B lymphocyte cDNA library and is predicted to
encode for a 54-kDa protein; however, recombinant RGS3
migrates at 75 kDa, as does the epitope-tagged version when
expressed in mammalian cells. A smaller RGS3 may be de-
rived from the 1.8-kb RGS3 mRNA transcript observed on
Northern blot analysis and can be accounted for by an mRNA
that splices from exon 2 to exon 4 deleting exon 3, which
encodes the first 326 amino acids of RGS3. Alternatively,
truncated forms of RGS3 may arise by another mechanism,
perhaps incomplete gene duplication, or by the use of an
alternative promoter (Chatterjee et al., 1997b). Our RGS3
antiserum would not recognize such proteins because it fails
to detect the N-terminal truncated RGS3. The RGS3 anti-
serum was also used to examine the effects of stimulation
through a GPCR on RGS3 expression in HS-Sultan cells.
Similar to RGS1, which can be induced in HS-Sultan cells by
treatment with platelet-activating factor (Druey et al., 1996),
Fig. 6. Effects of point mutations in RGS3 on G11aQ209L-mediated CREB
reporter gene activation. HEK 293T cells were transfected with con-
structs directing the expression of G11aQ209L (0.5 mg/plate), CREB-
galactosidase (0.5 mg/plate), and FLAG-RGS3 or various FLAG-RGS3
mutant proteins (1 mg/plate). b-Galactosidase levels were measured 24 h
later. The data are expressed as percentages of activation in comparison
to HEK 293T cells expressing G11aQ209L in the presence of a control
plasmid. Each value is the mean 6 2 S.D. of five experiments performed
in duplicate. An anti-FLAG immunoblot (bottom) shows that all mutant
proteins were expressed.
Fig. 7. Top, Effect of point mutations in RGS3 on GqaQ209L-induced
inositol phosphate generation. COS-7 cells were transfected with con-
structs directing the expression of GqaQ209L (0.2 mg/plate) and FLAG-
RGS3, FLAG-RGS4, FLAG-RGS3CT, FLAG-RGS3NT or various FLAG-
RGS3 mutant proteins (0.8 mg/plate). The accumulations of inositol
phosphates were measured during the last 15 h of a 48-h culture period.
The data are expressed as percentages of control (no RGS protein), and
each value is the mean 6 2 S.D. of five experiments performed in dupli-
cate. Middle, An anti-FLAG immunoblot indicates that all mutant pro-
teins were expressed. Bottom, A schematic of RGS3, RGS3CT, and the
various RGS3 mutants are shown.
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exposure of HS-Sultan cells to lysophosphatic acid resulted
in increased RGS3 expression.
Our results define RGS3 as a particularly potent regulator
of Gqa-mediated signaling. Although the GAP assay results
suggest that RGS4 and RGS3 have similar levels of activity
for Gqa, RGS3 proved more effective than RGS4 in inhibiting
signaling through the Gq-linked M1 muscarinic receptor.
The efficacy of RGS3 is unlikely related to its N-terminal
domain, because RGS3CT is more potent than is RGS3. Also,
we can conclude that the N-terminal domain of RGS3 does
not markedly influence RGS3 GAP activity because both
RGS3 and RGS3CT performed similarly in GAP assays.
However, it remains possible that an in vivo post-transla-
tional modification of the N terminus of RGS3 could alter its
GAP activity. The reported failure of RGS3 to inhibit Gq-
mediated signaling in BHK cells suggests that a modification
of RGS3 or the presence of an interacting protein may regu-
late its intracellular localization or GAP activity (Chatterjee
et al., 1997a). In fact, our experiments suggest that the
N-terminal RGS3 may limit its access to intracellular mem-
branes. Less of the full-length RGS3 localized at cell mem-
branes both before and after expression of GqaQ209L, a stim-
ulus that translocates RGS3 to cellular membranes.
The efficacy of RGS3 in inhibiting Gq-mediated signaling
is not likely explained solely on the basis of GPCR-RGS
protein interaction (Xu et al., 1999). Both RGS2 and RGS3
are superior to RGS4 in inhibiting Gq-mediated signaling
irrespective of the GPCR used. Furthermore, RGS3 and
RGS2 markedly inhibited signal transduction initiated by
Q209L mutants of Gqa and G11a , whereas RGS4 did not.
Because RGS4 does not act as a GAP for GqaQ209L under the
same conditions that it does for GqaR183C (P. Chediac, un-
published observation), a likely explanation for the efficacy of
RGS3 is that it inhibits GTP-bound Gqa from activating
downstream effectors. Previously, RGS2 was shown to be a
10- to 30-fold more potent inhibitor of GTP-gs-bound Gqa-
induced activation of phospholipase Cb than was RGS4
(Heximer et al., 1997). RGS10 also impaired activation of the
CREB reporter gene by GTPase-deficient forms of Gq. How-
ever RGS1 is like RGS4, a Gqa GAP (Moratz et al., 2000), but
incapable of blocking signaling by GTPase-deficient forms of
Gq.
What is the structural basis of the success of RGS2 and
RGS3 in inhibiting Gq/11aQ209L-mediated signal transduc-
tion? Comparison of the RGS domains of RGS2 and RGS3
with those of other RGS proteins that are not good inhibitors
does not reveal any compelling differences. The amino acid
residues in the three major contact sites defined in the RGS4/
Gia1 crystal structure are very similar between RGS3 and
RGS4. Several of these residues are undoubtedly important
in the interaction of RGS proteins with Gqa, because muta-
tions of them interferes with the inhibition by RGS3 of
G11aQ209L and GqaQ209L signaling. Mutations introduced
into the region just N terminal to the RGS domain of RGS3
also impaired RGS3 function. The KKL mutation in RGS3
significantly compromised the inhibitory activity of RGS3,
and yet these residues are conserved among many of the RGS
proteins that do not behave as Gqa-effector antagonists, sug-
gesting that other critical amino acids remain to be identi-
fied. A direct alignment of RGS2 and RGS3CT does reveal a
short stretch of conserved amino acids to the C-terminal side
of the KxxKxxL sequence (RGS2 residues 55–62 PGKPK-
TGK and RGS3 residues 366–373 PGAPPAGK) that are not
present in other RGS proteins. To approach the importance
of this region and the N-terminal portions of RGS2 and RGS3
in general, fusion proteins between the N terminus of RGS3
and the C terminus of RGS4 will be made to test whether we
can convert RGS4 into a more potent Gq-effector antagonist.
Because the existence of RGS proteins that act as GAPs for
Gsa remains a possibility and because we had observed an
inhibition of Gs-mediated signaling, we were interested to
examine whether RGS3 had Gsa GAP activity. When tested
in a standard GAP assay, RGS3 failed to enhance the GTPase
activity of Gsa. One caveat in interpreting the GAP data is
Fig. 8. Membrane localization of RGS3 and
RGS3CT. A, Dose response to RGS3 and RGS3CT.
COS-7 cells were transfected with constructs di-
recting the expression of GqaQ209L (0.2 mg/plate)
and various amounts of either FLAG-RGS3 or
FLAG-RGS3T. The accumulations of inositol
phosphates were measured during the last 15 h of
a 48-h culture period. The data are expressed as
percentages of control (no RGS protein), and each
value is the mean of two experiments. An anti-
FLAG immunoblot shows the expression levels of
RGS3 and RGS3CT. B, Distribution of RGS3 and
RGS3CT at cellular membranes. Cell lysates pre-
pared from COS-7 cells transfected with con-
structs directing the expression of GqaQ209L and
increasing concentrations (0.2, 0.4, and 0.8 mg) of
FLAG-RGS3 or FLAG-RGS3CT were fractionated
into membrane-enriched (Memb.) and membrane-
depleted fractions (Supernat.) and subjected to
FLAG immunoblotting. The immunoblot was re-
probed with an antiserum directed against Gia
proteins to verify equal loading of the cell mem-
branes. This experiment was performed three
times with similar results.
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that the assays in this study were done in the absence of
receptors; therefore, it remains possible that RGS3 is a Gsa
GAP in the presence of the appropriate receptor. A precedent
for such a possibility is that the Ga specificity of RGS2 was
only revealed in the presence of a receptor (Ingi et al., 1999).
In preliminary experiments we found that the expression of
RGS3 also inhibited the activation of the CREB reporter by a
GTPase-deficient form of Gsa (J. Yuen, unpublished obser-
vation). Although the physiologic relevance of these observa-
tions needs further clarification, this is the third study to
show that RGS proteins may modify Gs signaling (Chatterjee
et al., 1997a; Tseng and Zhang, 1998).
Recently, we found RGS3 to be a more effective inhibitor
than RGS1, RGS2, or RGS4 of interleukin-8 and MCP-1-
directed migration of a pre-B lymphocyte cell line (Bowman
et al., 1998). Because chemotaxis is dependent on the release
of bg-subunits from Gia-subunits (Arai et al., 1997; Neptune
and Bourne, 1997), RGS3 may be among the most potent of
the RGS proteins in inhibiting Gi-linked signaling pathways.
Thus, RGS3 emerges as a potent inhibitor of both Gia and Gqa
signaling. Its effectiveness as an inhibitor of Gq-signaling
likely arises from both its Gqa GAP activity and its ability to
inhibit signaling by GTP-bound Gqa and G11a. The function of
the extended N terminus of RGS3 remains unknown; how-
ever, it is unlikely to account for the superiority of RGS3 in
inhibiting Gi- and Gq-linked signaling pathways. Based on
the signaling and cellular localization studies the N terminus
may have a role in regulating the access of RGS3 to cellular
membranes.
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